ArticleMolecular medicine (Cambridge, Mass.)2024

Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients.

Xiaoqing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.